Neurocrine Biosciences, Inc. (NBIX)
167.40
-2.00
(-1.18%)
USD |
NASDAQ |
Nov 13, 16:00
167.38
-0.02
(-0.01%)
After-Hours: 19:59
Neurocrine Biosciences Price : 167.40 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 169.96 | 171.16 | 164.65 | 167.40 | 1.381M |
| Nov 12, 2026 | 173.98 | 173.98 | 169.22 | 169.40 | 1.346M |
| Nov 11, 2026 | 168.92 | 174.59 | 168.09 | 174.41 | 1.145M |
| Nov 10, 2026 | 168.81 | 169.50 | 166.56 | 169.14 | 1.059M |
| Nov 09, 2026 | 166.66 | 169.89 | 162.99 | 168.86 | 1.525M |
| Nov 06, 2026 | 159.98 | 165.86 | 158.66 | 164.63 | 1.507M |
| Nov 05, 2026 | 167.68 | 167.68 | 159.50 | 159.76 | 1.483M |
| Nov 04, 2026 | 166.36 | 169.02 | 162.02 | 166.05 | 2.267M |
| Nov 03, 2026 | 159.00 | 169.53 | 157.91 | 164.85 | 4.057M |
| Nov 02, 2026 | 145.70 | 147.57 | 143.75 | 145.35 | 2.018M |
| Oct 30, 2026 | 147.13 | 149.25 | 145.22 | 146.10 | 1.322M |
| Oct 29, 2026 | 146.57 | 147.17 | 145.37 | 146.38 | 831120.0 |
| Oct 28, 2026 | 144.56 | 145.98 | 143.00 | 145.53 | 1.092M |
| Oct 27, 2026 | 145.01 | 146.59 | 143.91 | 146.00 | 1.179M |
| Oct 26, 2026 | 143.99 | 146.00 | 142.34 | 145.87 | 1.285M |
| Oct 23, 2026 | 142.74 | 143.83 | 140.90 | 142.70 | 1.033M |
| Oct 22, 2026 | 141.62 | 143.83 | 140.75 | 143.29 | 1.245M |
| Oct 21, 2026 | 141.38 | 142.77 | 140.84 | 141.31 | 815513.0 |
| Oct 20, 2026 | 138.51 | 142.09 | 137.90 | 142.00 | 1.258M |
| Oct 19, 2026 | 136.34 | 137.53 | 135.00 | 136.98 | 1.050M |
| Oct 16, 2026 | 137.86 | 138.20 | 135.55 | 135.71 | 1.127M |
| Oct 15, 2026 | 137.26 | 138.23 | 135.55 | 136.95 | 1.379M |
| Oct 14, 2026 | 133.94 | 136.57 | 132.25 | 135.91 | 1.507M |
| Oct 13, 2026 | 139.60 | 139.92 | 134.89 | 135.13 | 1.568M |
| Oct 12, 2026 | 142.37 | 143.62 | 140.89 | 141.37 | 1.092M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 465.67 |
| BioCryst Pharmaceuticals, Inc. | 7.61 |
| Halozyme Therapeutics, Inc. | 100.27 |
| Iovance Biotherapeutics, Inc. | 7.76 |
| Precigen, Inc. | 4.54 |
Price Related Metrics
| PE Ratio | 24.82 |
| PS Ratio | 4.709 |
| PEG Ratio | 0.4064 |
| Price to Book Value | 4.372 |
| Price to Free Cash Flow | 17.91 |
| Earnings Yield | 4.03% |
| Market Cap | 16.96B |
| PEGY Ratio | 0.4064 |
| Operating PE Ratio | 19.16 |
| Normalized PE Ratio | 23.12 |